Drugs for GU Disorders Flashcards
2 manifestations of benign prostatic hyperplasia
- Painful/difficult urination (compression of urethra)
- Frequent urination (compression of bladder)
Dynamic pathogenic cause of BPH
Excessive alpha-adrenergics
Static pathogenic causes of BPH
- Epithelial hyperplasia via androgens
- Stromal hyperplasia via estrogens
Which causes of BPH can be treated clinically?
- Alpha-adrenergic excess
- Epithelial hyperplasia via androgens
FIRST CHOICE for treating BPH?
Why? (5)
Alpha-1 antagonists
Faster acting, more effective, does not affect PSA level, does not reduce prostate size, has less sexual dysfunction
Terazosin
Second-generation alpha-1 antagonist
Treatment of BPH
Side effects = orthostatic hypotension, syncope, dizziness
Requires does titration
Doxazosin
Second-generation alpha-1 antagonist
Treatment of BPH
Side effects = orthostatic hypotension, syncope, dizziness
Requires dose titration
Alfuzosin
Second-generation alpha-1 antagonist
Treatment of BPH
UROSELECTIVE - no systemic side effects
Does NOT require dose titration
Alpha-1 receptors involved in BPH
1A = prostatic smooth muscle 1B = vasculature
Tamsulosin
Third-generation alpha-1 antagonist
Treatment of BPH
Alpha-1A > Alpha-1B
Silodosin
Third-generation alpha-1 antagonist
Treatment of BPH
ALPHA-1A (HIGHLY SELECTIVE)
NO orthostatic hypotension
Side effects of second-generation alpha-1 antagonists
Syncope, dizziness, hypotension
Side effect of third-generation alpha-1 antagonists
Ejaculatory dysfunction
Drug interactions?????
h
5-alpha reductase
Types?
Converts testosterone to DHT
Type 1 = skin, hair, liver
Type 2 = prostate, genitals, scalp
Important 5-alpha reductase for BPH?
Type 2 - causes epithelial portion enlargement in prostate
Maximal size decrease of prostate by 5-alpha reductase inhibitor?
20% - portion due to epithelial tissue
When are 5-alpha reductase inhibitors preferred?
- SEVERELY enlarged prostate (>40g)
- Contraindications to adrenergic antagonists
Patient with large prostate and high PSA is treated how?
Combo therapy of reductase inhibitors + alpha-1 antagonist
Adverse effects of reductase inhibitors
Sexual dysfunction (multiple)
Teratogenesis (pregnancy)
Increased risk of INVASIVE prostate cancer
Gynecomastia, muscle weakness, abdominal pain
Patient has BPH. What do you NOT give him? (3)
- Testosterone
- Alpha agonists (decongestant - phenylephrine, ephedrine)
- Antimuscarinics (antihistamine, antidepressant, atropine, anti-Parkinson’s drugs)
Finasteride
SELECTIVE type 2 5-alpha reductase inhibitor
Treats BPH
Dutasteride
NON-selective (types 1 and 2) 5-alpha reductase inhibitor
Treats BPH
Patient has hypogonadism. Treat with what?
Testosterone replacement